UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - inflammatory+diseases
19
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
2013-741 Bioengineered Thymic Aggregates for Implantation
Bioengineered Thymic Aggregates For ImplantationSUMMARYResearchers led by Gay Crooks from the Department of Pathology and Laboratory Medicine at UCLA have bioengineered a thymus implant to treat immune diseases.BACKGROUNDThe thymus plays an important role in the immune cells by producing specialized white blood cells called T cells. Thymus implantation...
Published: 2/14/2025
|
Inventor(s):
Gay Crooks
,
Amelie Montel-Hagen
,
Brile Chung
Keywords(s):
Autoimmune
,
Drug Delivery
,
Hematology
,
Inflammatory Diseases
,
Other Polymers
,
Therapeutics & Vaccines
Category(s):
Platforms > Drug Delivery
,
Therapeutics > Autoimmune
,
Therapeutics > Hematology
,
Platforms > Drug Delivery > Other Polymers
,
Therapeutics > Immunology And Immunotherapy
2019-641 LATE TRANSITION METAL MEDIATED BASE PAIRS AND APPLICATIONS IN BIOTECHNOLOGY AND SYNTHESIS
UCLA researchers in the Department of Chemistry and Biochemistry have developed a novel method of metal-mediated base pair stabilization in vivo, with additional applications in the detection of small nucleic acids and regulation of transition metal catalysis. BACKGROUND:Recent studies of the interactions between transition metals and DNA have led...
Published: 2/14/2025
|
Inventor(s):
Hosea Nelson
Keywords(s):
Catalysts
,
Chemical Manufacturing & Industrial/Bulk Chemicals
,
Inflammatory Diseases
,
Life Science Research Tools
,
Other
,
Therapeutics & Vaccines
Category(s):
Chemical > Synthesis
,
Therapeutics > Inflammation And
Inflammatory Diseases
2019-876 MAINTAINING FUNCTIONS AND PHENOTYPES OF CONNECTIVE TISSUE THROUGH NPAS2 SUPPRESSION
UCLA researchers in the Departments of Dentistry and Plastic Surgery have developed a novel suppressor of Npas2 for the regeneration of connective tissues.BACKGROUND:Open wounds of the skin and oral cavity are subject to infection and scarring if not properly closed. Patients may experience a variety of social consequences due to unclosed wounds of...
Published: 2/14/2025
|
Inventor(s):
Ichiro Nishimura
,
Akishige Hokugo
,
Hodaka Sasaki
,
Hiroko Okawa
,
Lixin Wang
Keywords(s):
Dental
,
Inflammatory Diseases
,
Therapeutics & Vaccines
Category(s):
Therapeutics > Dental
,
Therapeutics > Inflammation And
Inflammatory Diseases
2019-958 SELECTIVE HDAC INHIBITORS
UCLA researchers in the Department of Chemistry and Biochemistry have synthesized a series of novel hydroxamic acids and derivatives as selective histone deacetylase (HDAC) inhibitors from simple starting materials.BACKGROUND:Histone deacetylase (HDAC) inhibitors are chemical compounds that regulates gene expression by inhibiting histone deacetylases....
Published: 2/14/2025
|
Inventor(s):
Michael Jung
,
Jonghoon Kim
Keywords(s):
Chemical Manufacturing & Industrial/Bulk Chemicals
,
Cns
,
Gene Editing Systems
,
Gene Therapy
,
Infectious Diseases
,
Inflammatory Diseases
,
Therapeutics & Vaccines
Category(s):
Therapeutics > CNS and Neurology
,
Therapeutics > Infectious Diseases
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Inflammation And
Inflammatory Diseases
,
Chemical > Industrial & Bulk Chemicals
Early Prediction of Progression in Idiopathic Pulmonary Fibrosis Using a Single Time Point HRCT Scan (Case No. 2019-731)
Summary: UCLA researchers in the Department of Radiological Sciences have developed a novel single time point high-resolution computed tomography (HRCT) scan method for the early prediction of idiopathic pulmonary fibrosis disease progression. Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease that results in scarring of the lungs...
Published: 4/30/2025
|
Inventor(s):
Grace Hyun Kim
,
Jonathan Goldin
Keywords(s):
CT
,
Diagnostic Markers & Platforms
,
Inflammatory Diseases
,
Life Science Research Tools
,
Medical Imaging
,
Microscopy And Imaging
Category(s):
Life Science Research Tools > Microscopy And Imaging
,
Medical Devices > Medical Imaging > CT
,
Therapeutics > Inflammation And
Inflammatory Diseases
2019-468 PERIODONTAL MICROPATCH AND USES THEREOF
INTRODUCTION:UCLA researchers in the Departments of Bioengineering and Dentistry have developed a patch-based drug delivery system for dental applications.BACKGROUND:Periodontitis is a chronic inflammatory disease that affects tissues surrounding the teeth, and it is estimated that 50% of the U.S. population suffers from some type of periodontal disease....
Published: 2/14/2025
|
Inventor(s):
Keywords(s):
Dental
,
Drug Delivery
,
Inflammatory Diseases
,
Medical Devices and Materials
,
Other Polymers
Category(s):
Platforms > Drug Delivery > Other Polymers
2016-518: Inhibition of Protein Tyrosine Phosphatase-Sigma for Hematopoietic Regeneration
Inhibition Of Protein Tyrosine Phosphatase - Sigma For Hematopoietic RegenerationSUMMARYUCLA Researchers have identified a novel pharmacological target for hematopoietic stem cell regeneration. They have developed small molecule inhibitors against the target and shown that the inhibitors cause rapid stem cell regeneration.BACKGROUNDDepletion of white...
Published: 2/14/2025
|
Inventor(s):
John Chute
,
Michael Jung
,
Emelyne Diers
Keywords(s):
Autoimmune
,
Hematology
,
Inflammatory Diseases
,
iPS/stem cells
,
Oncology
Category(s):
Therapeutics > Autoimmune
,
Therapeutics > Oncology
,
Therapeutics > Hematology
,
Therapeutics > Inflammation And
Inflammatory Diseases
,
Therapeutics > Stem Cells And Regenerative Medicine > Ips Stem Cells
2018-388 METABOLIC REQUIREMENTS FOR ALTERNATIVE MACROPHAGE ACTIVATION
Metabolic Requirements for Alternative Macrophage ActivationSUMMARYUCLA researchers in the Department of Molecular and Medical Pharmacology have discovered that Coenzyme A is a targetable requirement for anti-inflammatory macrophage differentiation.BACKGROUNDA dysregulated immune response is a hallmark of many disease phenotypes. For instance, cancer...
Published: 2/14/2025
|
Inventor(s):
Steven Bensinger
,
Ajit Divakaruni
,
Anne Murphy
,
Wei Yuan Hsieh
Keywords(s):
Autoimmune
,
Drug Delivery
,
Infectious Diseases
,
Inflammatory Diseases
,
Therapeutics & Vaccines
Category(s):
Platforms > Drug Delivery
,
Therapeutics
,
Therapeutics > Autoimmune
,
Therapeutics > Infectious Diseases
,
Therapeutics > Inflammation And
Inflammatory Diseases
Antitumor Activity Of Sd-101 Alone Or In Combination With A-Pd-1 Therapy In Tumors Resistant To Anti-Pd-1
SummaryUCLA researchers in the Department of Medicine have developed a novel antitumor treatment that works alone or in combination with anit-PD-1 therapy to target interferon signaling-deficient tumors or tumors with alterations in the antigen presentation machinery, that are resistant to anti-PD-1 therapy.BackgroundProgrammed cell death protein 1...
Published: 2/14/2025
|
Inventor(s):
Keywords(s):
Immunotherapy
,
Inflammatory Diseases
,
Life Science Research Tools
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Therapeutics
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Inflammation And
Inflammatory Diseases
2018-159 Therapeutic Approach to Prevent or Alleviate Drug-, Noise- and Age-Related Hearing Loss
Therapeutic Approach To Prevent Or Alleviate Drug-, Noise- And Age-Related Hearing LossSUMMARYUCLA researchers in the Department of Head and Neck Surgery have developed a novel therapeutic approach to treating hearing loss using inflammation-resolving molecules.BACKGROUNDMore than 350 million people worldwide exhibit some degree of hearing loss, with...
Published: 2/14/2025
|
Inventor(s):
Jennifer Long
,
Federico Kalinec
Keywords(s):
Drug Delivery
,
Inflammatory Diseases
,
Nanoparticles
,
Therapeutics & Vaccines
Category(s):
Platforms > Drug Delivery
,
Therapeutics
,
Therapeutics > Inflammation And
Inflammatory Diseases
,
Platforms > Drug Delivery > Nanoparticles
1
2